Which has the lower trailing P/E, ALNY or GEHC?

GEHC has the lower trailing P/E: ALNY trades at 40.05 and GEHC at 20.79. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ALNY or GEHC?

Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus GEHC at 3.74%.

Does ALNY or GEHC pay a bigger dividend?

GEHC pays a dividend (0.20% yield), while ALNY has no payments in the available dividend history.

Is ALNY or GEHC more profitable?

ALNY runs the higher net margin — ALNY at 16.82% versus GEHC at 7.86%.

Alnylam Pharmaceuticals, Inc. (ALNY) vs GE HealthCare Technologies Inc. (GEHC)

A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and GE HealthCare Technologies Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 29, 2026. Differences are shown without an overall score or investment verdict.

ALNY

Alnylam Pharmaceuticals, Inc.

$31.73B

$237.10HealthcareAt close: Aug 28, 2026, 4:00 PM ET

GEHC

GE HealthCare Technologies Inc.

$32.40B

$71.72HealthcareAt close: Aug 28, 2026, 4:00 PM ET

Total return — ALNY vs GEHC

growth of $100 · dividends reinvested · last 4y

ALNY +0.1% (+0.0%/yr)GEHC +20.2% (+4.7%/yr)GEHC compounded faster over this window

ALNY GEHC

ALNY vs GEHC: by the numbers

•GEHC is the larger company ($32.40B vs $31.73B market cap).
•GEHC trades at the lower trailing earnings multiple (20.79 vs 40.05 P/E), one valuation lens rather than an overall verdict.
•ALNY converts more revenue to profit (16.82% vs 7.86% net margin).
•ALNY grew revenue faster over the past five years (47.53% vs 3.74% CAGR).
•GEHC pays a dividend (0.20% yield), while ALNY has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ALNY	GEHC
P/E ratio	40.05	20.79
Forward P/E	36.43	14.56
P/S ratio	6.82	1.61
P/B ratio	24.21	2.97
EV / EBITDA	30.68	11.33
FCF yield	1.66%	2.75%

Profitability

Metric	ALNY	GEHC
Gross margin	79.72%	42.90%
Operating margin	20.81%	12.70%
Net margin	16.82%	7.86%
ROE	59.67%	14.51%
ROIC	24.71%	6.94%

Dividends

Metric	ALNY	GEHC
Dividend yield	N/A	0.20%
Payout ratio	N/A	3.07%

Growth (annualized)

Metric	ALNY	GEHC
Revenue CAGR (5Y)	47.53%	3.74%
EPS CAGR (5Y)	N/A	0.67%
FCF CAGR (5Y)	N/A	1.07%
Total return CAGR (5Y)	3.06%	N/A

Frequently asked

Which has the lower trailing P/E, ALNY or GEHC?: GEHC has the lower trailing P/E: ALNY trades at 40.05 and GEHC at 20.79. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ALNY or GEHC?: Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus GEHC at 3.74%.
Does ALNY or GEHC pay a bigger dividend?: GEHC pays a dividend (0.20% yield), while ALNY has no payments in the available dividend history.
Is ALNY or GEHC more profitable?: ALNY runs the higher net margin — ALNY at 16.82% versus GEHC at 7.86%.

Go deeper

Full ALNY analysis Full GEHC analysis Interactive comparison tool

Dig into the metrics

Alnylam Pharmaceuticals P/E ratio GE HealthCare Technologies P/E ratio GE HealthCare Technologies dividend yield Alnylam Pharmaceuticals ROE GE HealthCare Technologies ROE Alnylam Pharmaceuticals operating margin GE HealthCare Technologies operating margin Alnylam Pharmaceuticals revenue growth GE HealthCare Technologies revenue growth Alnylam Pharmaceuticals free cash flow GE HealthCare Technologies free cash flow

Alnylam Pharmaceuticals & GE HealthCare Technologies appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 29, 2026.